Skip to main content

U.S. Pharmaceutical Sales - Q1 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q1 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q1 2013 by Units Sold

Rank Drug Units (000)
1 budesonide
Generic
0.81% Stats
2 acetaminophen/hydrocodone
Generic
-2.92% Stats
3 () omeprazole
Generic
n/a Stats
4 (1) ProAir HFA
Teva Pharmaceuticals USA, Inc.
-11.64% Stats
5 (1) Nexium
AstraZeneca
-2.47% Stats
6 (1) Cymbalta
-2.09% Stats
7 (1) atorvastatin
Generic
4.70% Stats
8 (1) OneTouch
-0.70% Stats
9 Ventolin HFA
GlaxoSmithKline
1.27% Stats
10 Advair Diskus
GlaxoSmithKline
1.81% Stats
11 (5) Lantus
Sanofi
-9.19% Stats
12 (1) Lantus Solostar
Sanofi
5.57% Stats
13 enoxaparin
Generic
-0.90% Stats
14 (9) Tamiflu
67.13% Stats
15 (1) Crestor
AstraZeneca
-2.93% Stats
16 (4) fentanyl
Generic
-6.62% Stats
17 (2) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
-1.50% Stats
18 (1) Levemir
Novo Nordisk
4.92% Stats
19 (3) Novolog
Novo Nordisk
-10.03% Stats
20 (2) NovoLog FlexPen
Novo Nordisk
-1.52% Stats
21 (4) metoprolol
Generic
16.39% Stats
22 (2) Humalog
Eli Lilly and Company
2.85% Stats
23 (1) Nasonex
Merck
4.32% Stats
24 Synthroid
AbbVie Inc.
1.22% Stats
25 (4) Abilify
Otsuka Pharmaceutical Co., Ltd
-5.89% Stats
26 Januvia
Merck
0.38% Stats
27 Symbicort
AstraZeneca
-4.45% Stats
28 (1) Lyrica
Pfizer Inc.
0.29% Stats
29 (1) Suboxone
0.58% Stats
30 (2) Namenda
Allergan plc
-3.55% Stats
31 Zetia
Merck
0.86% Stats
32 (1) Diovan
Novartis Pharmaceuticals Corporation
1.75% Stats
33 (1) Flovent HFA
GlaxoSmithKline
-2.80% Stats
34 Combivent
Boehringer Ingelheim Pharmaceuticals, Inc.
-1.89% Stats
35 (16) AndroGel
AbbVie Inc.
-40.11% Stats
36 (1) Lidoderm
Endo Pharmaceuticals Inc.
-5.23% Stats
37 (5) fenofibrate
Generic
26.11% Stats
38 (1) Remicade
Janssen Pharmaceuticals, Inc.
2.51% Stats
39 (3) Lovaza
GlaxoSmithKline
-4.33% Stats
40 (1) Benicar
Daiichi Sankyo
-0.27% Stats
41 (1) Dexilant
Takeda Pharmaceutical Company Limited
0.13% Stats
42 (4) Restasis
Allergan plc
-3.62% Stats
43 OxyContin
Purdue Pharma LP
-5.47% Stats
44 () Benicar HCT
Daiichi Sankyo
n/a Stats
45 () Humalog KwikPen
Eli Lilly and Company
n/a Stats
46 (1) VESIcare
Astellas Pharma US, Inc.
6.03% Stats
47 (3) Vytorin
Merck
-4.30% Stats
48 (2) Celebrex
Pfizer Inc.
-4.90% Stats
49 (1) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
-0.20% Stats
50 (1) Janumet
Merck
-0.61% Stats
51 (4) Enbrel
Amgen Inc.
-6.83% Stats
52 (2) Niaspan
AbbVie Inc.
-4.25% Stats
53 (2) Evista
-4.25% Stats
54 () doxycycline
Generic
n/a Stats
55 () hydrochlorothiazide/valsartan
Generic
n/a Stats
56 (1) Cialis
Eli Lilly and Company
2.20% Stats
57 (5) methylphenidate
Generic
-1.90% Stats
58 (4) Vyvanse
Takeda Pharmaceutical Company Limited
-2.75% Stats
59 (3) amphetamine/dextroamphetamine
Generic
-0.13% Stats
60 (3) Aciphex
Eisai Inc.
-10.56% Stats
61 (3) Humira
AbbVie Inc.
-5.68% Stats
62 Victoza
Novo Nordisk
9.76% Stats
63 (3) Epogen
Amgen Inc.
-2.64% Stats
64 (5) Rebif
EMD Serono, Inc.
-8.17% Stats
65 (2) Rituxan
Genentech, Inc.
1.82% Stats
66 (5) Truvada
Gilead Sciences, Inc.
-8.51% Stats
67 (1) Atripla
Gilead Sciences, Inc.
-0.83% Stats
68 (1) Avastin
Genentech, Inc.
n/a Stats
69 (5) Viagra
Pfizer Inc.
-12.48% Stats
70 (2) Seroquel XR
AstraZeneca
-4.69% Stats
71 (2) modafinil
Generic
-6.78% Stats
72 (2) Renvela
Sanofi
-1.39% Stats
73 (2) Lunesta
Sunovion Pharmaceuticals Inc.
-2.61% Stats
74 (1) Neulasta
Amgen Inc.
4.11% Stats
75 (3) Adderall XR
Takeda Pharmaceutical Company Limited
-3.26% Stats
76 (3) Orencia
Bristol-Myers Squibb Company
-0.91% Stats
77 (3) Sensipar
Amgen Inc.
-4.92% Stats
78 (2) Focalin XR
Novartis Pharmaceuticals Corporation
-5.21% Stats
79 (1) Xolair
-0.72% Stats
80 (3) Procrit
Janssen Pharmaceuticals, Inc.
-3.23% Stats
81 (1) Isentress
Merck
-0.37% Stats
82 (3) Reyataz
Bristol-Myers Squibb Company
-5.42% Stats
83 (2) Aranesp
Amgen Inc.
-4.63% Stats
84 (1) Prezista
Janssen Pharmaceuticals, Inc.
-0.41% Stats
85 (1) Lucentis
Genentech, Inc.
6.14% Stats
86 (3) Synagis
MedImmune, Inc.
44.24% Stats
87 (5) Copaxone
Teva Pharmaceuticals USA, Inc.
-8.03% Stats
88 (2) Alimta
Eli Lilly and Company
-9.60% Stats
89 (1) Herceptin
Genentech, Inc.
1.83% Stats
90 (2) Neupogen
Amgen Inc.
-4.12% Stats
91 (4) Prevnar 13
Pfizer Inc.
-13.97% Stats
92 (1) Zyvox
Pfizer Inc.
11.81% Stats
93 (1) Xgeva
Amgen Inc.
5.17% Stats
94 (1) Avonex
Biogen
-13.39% Stats
95 (1) Gleevec
Novartis Pharmaceuticals Corporation
-5.75% Stats
96 (1) Xeloda
Genentech, Inc.
-9.23% Stats
97 Betaseron
Bayer HealthCare Pharmaceuticals Inc.
-6.56% Stats
98 Gilenya
Novartis Pharmaceuticals Corporation
-1.75% Stats
99 Stelara
Janssen Pharmaceuticals, Inc.
4.35% Stats
100 Incivek
Vertex Pharmaceuticals Incorporated
-12.50% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.